SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverKVUE
ConsumerNYSEUSD

Kenvue

$0012345678900123456789.0012345678900123456789+3.2%
52w low (est.) $15.56$23.62 52w high (est.)
Peers
Market data
Market cap
$37.40B
52-week range
$14.02 – $22.87
Beta (vs market)
0.44
Sector
Consumer
Valuation
P/E ratio
23.2x
DCF fair value
$32.34
Margin of safety
+70.0%
Forward P/E
15.7x
PEG ratio
1.60
Dividend yield
4.33%
Quality & efficiency
Moat score
64/100
Return on equity
15.7%
Profit margin
10.6%
Debt / equity
0.83
Growth & analysts
Revenue growth (YoY)
+4.5%
Analyst target
$19.58
Target upside
+3.0%
Analysts covering
12

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Valuation

ValueGrowthProfitHealthIncome62QUALITY
Overall Rating
71
Strong Buy
Strong Buy
Moat Score64
DCF Intrinsic Value
$32.34+70.0% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$37.40B
P/E Ratio
23.2
Dividend Yield
4.33%
Revenue Growth
+4.5%
Profit Margin
10.6%
ROE
15.7%
Debt / Equity
0.83
Beta
0.44
Dividend Aristocrats
vs Consumer sector:P/E 23 vs 29 · cheaperMoat 64 vs 5Yield 4.33% vs 0.1%

Statistics

Similar Stocks · Consumer

COST70
$900.00+0.3%
HD69
$410.00+0.2%
ULVR.L69
£46.00+0.2%
AMZN68
$186.40+1.1%

Latest News · KVUE